Cargando…
Tissue Specific Promoters in Colorectal Cancer
Colorectal carcinoma is the third most prevalent cancer in the world. In the most advanced stages, the use of chemotherapy induces a poor response and is usually accompanied by other tissue damage. Significant progress based on suicide gene therapy has demonstrated that it may potentiate the classic...
Autores principales: | Rama, A. R., Aguilera, A., Melguizo, C., Caba, O., Prados, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662999/ https://www.ncbi.nlm.nih.gov/pubmed/26648599 http://dx.doi.org/10.1155/2015/390161 |
Ejemplares similares
-
Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives
por: Hernández, Rosa, et al.
Publicado: (2018) -
Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter
por: Rama, Ana R., et al.
Publicado: (2015) -
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
por: Melguizo, Consolación, et al.
Publicado: (2015) -
Proteomic biomarkers in body fluids associated with pancreatic cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2018) -
Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review
por: Cepero, Ana, et al.
Publicado: (2022)